Skip to main content
Log in

Systemic candidiasis in mice treated with prednisolone and amphotericin B. 2. Ultrastructure and evidence for fungal toxin

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

The principal ultrastructural changes in cells of Candida albicans treated with amphotericin B (AmB), either in vitro or in vivo, and in the presence or absence of prednisolone included plasmolysis, vacuolation and destruction of organelles. Lamination of the cell wall, although discernible after 4 h antibiotic treatment in vitro, was conspicuous in vivo, especially in prednisolone-treated mice given AmB 72 h after inoculation and was seen in both phagocytosed cells and those free in inflammatory exudates. Somatic extracts from control cells and somatic extracts and leachates from AmB-treated cells showed the presence of low-grade toxic components when given i.p. to mice receiving actinomycin D(AMD) s.c. Culture filtrates were negative. Eighteen hour cultures were more toxic than those grown for 3 days and no toxicity was shown for cultures after 8 or 14 days. The behaviour of toxic materials during electrophoresis in polyacrylamide gels suggested that they were proteins of relatively high molecular weight.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bakerspigel, A. 1964. Some observations on the cytology of Candida albicans. J. Bact. 87: 228–230.

    Google Scholar 

  2. Blyth, W. & Stewart, Gwendoline E. 1978. Systemic candidiasis in mice treated with prednisolone and amphotericin B. 1. Morbidity, mortality and inflammatory reaction. Mycophathologia.

  3. Chattaway, F.W., Odds, F.C. & Barlow, A.J.E. 1971. An examination of the production of hydrolytic enzymes and toxins by pathogenic strains of Candida albicans. J. gen. Microbiol. 67: 255–263.

    Google Scholar 

  4. Denning, T.J.Y. & Davies, R.R. 1973. Candida albicans and the chemotaxis of polymorphonuclear neutrophils. Sabouraudia 11: 210–221.

    Google Scholar 

  5. Gale, E.F., Johnson, Alison M., Kerridge, D. & Koh, T.Y. 1975. Factors affecting the changes in amphotericin sensitivity of Candida albicans during growth. J. gen. Microbiol. 87: 20–36.

    Google Scholar 

  6. Gale, G.R. 1963. Cytology of Candida albicans as influenced by drugs acting on the cytoplasmic membrane. J.Bact. 86: 151–157.

    Google Scholar 

  7. Hammond, S.M. & Kliger, B.N. 1974. Studies on the role of the cell wall of Candida albicans in the mode of action of polyene antibiotics. Proc. Soc. Gen. Microbiol. 1: 45.

    Google Scholar 

  8. Isenberg, H.D., Allerhand, J. & Berkman, J. 1963. An endotoxin-like fraction extracted from the cells of Candida albicans. Nature, London. 197: 516–517.

    Google Scholar 

  9. Iwata, K. & Uchida, K. 1967. ‘Canditoxin’ 2. Isolation and purification of the toxic substance. Medicine and Biology (Tokyo) 74: 351–356.

    Google Scholar 

  10. Iwata, K., Uchida, K., Yamaguchi, H. & Nozu, Y. 1972. Studies on the toxins produced by Candida albicans with special reference to their etiopathological role. ‘Yeasts and Yeast-like Microorganisms in Medical Science’, (ed. Iwata, K.) pp. 184–190. University of Tokyo Press.

  11. Kobayshi, G.S. & Friedman, L. 1964. Characterization of the pyrogenicity of Candida albicans, Saccharomyces cerevisiae and Cryptococcus neoformans. J. Bact. 88: 660–666.

    Google Scholar 

  12. Lampen, J.O. 1966. Interference by polyenic fungal antibiotics (especially nystatin and filipin) with specific membrane functions. Symp. Soc. gen. Microbiol. 16: 111–130.

    Google Scholar 

  13. Montes, L.F., Patrick, T.A., Martin, S.A. & Smith, M. 1965. Ultrastructure of blastospores of Candida albicans after permanganate fixation. J. invest. Derm. 45: 227–232.

    Google Scholar 

  14. Montes, L.F. & Wilborn, W.H. 1968. Ultrastructural features of hostparasite relationship in oral candidiasis. J. Bact. 96: 1349–1356.

    Google Scholar 

  15. Mourad, S. & Friedman, L. 1961. Pathogenicity of Candida. J. Bact. 81: 550–556.

    Google Scholar 

  16. Müller, J., Douchet, C. & Sukuma, S. 1972. Electron microscopic studies on the host-parasite relationship of the experimental Candida albicans infection of the mouse: the Candida granuloma in the kidney. ‘Yeasts and Yeast-like Microorganisms in Medical Science’, (ed. Iwata, K.) pp. 178–183. University of Tokyo Press.

  17. Partridge, Betty M. & Drew, J. Anne. 1974. Candida protoplasts and their ultrastructure. Sabouraudia 12: 166–178.

    Google Scholar 

  18. Pieroni, R.E. & Levine, L. 1970. Use of actinomycin D for quantitation of endotoxins in Pertussis vaccine and extracts. Symp. Series Immunobiol. Standard. 13: 198–202.

    Google Scholar 

  19. Polak, A. & Scholer, H.. 1976. Combination of amphotericin B and 5-fluorocytosine. Chemotherapy 6: 137–142.

    Google Scholar 

  20. Salvin, S.B. 1952. Endotoxin in pathogenic fungi. J. J. Immun. 69: 89–99.

    Google Scholar 

  21. Winner, H.I. 1956. Immunity in experimental moniliasis. J. Path. Bact. 71: 234–237.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blyth, W., Stewart, G.E. Systemic candidiasis in mice treated with prednisolone and amphotericin B. 2. Ultrastructure and evidence for fungal toxin. Mycopathologia 66, 51–57 (1978). https://doi.org/10.1007/BF00429593

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00429593

Keywords

Navigation